Review



il17a  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 95

    Structured Review

    R&D Systems il17a
    Il17a, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 83 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/il17a/product/R&D Systems
    Average 95 stars, based on 83 article reviews
    il17a - by Bioz Stars, 2026-05
    95/100 stars

    Images



    Similar Products

    94
    TargetMol recombinant mouse il 17a protein
    Recombinant Mouse Il 17a Protein, supplied by TargetMol, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/recombinant mouse il 17a protein/product/TargetMol
    Average 94 stars, based on 1 article reviews
    recombinant mouse il 17a protein - by Bioz Stars, 2026-05
    94/100 stars
      Buy from Supplier

    93
    MedChemExpress recombinant mouse il 17a
    Recombinant Mouse Il 17a, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/recombinant mouse il 17a/product/MedChemExpress
    Average 93 stars, based on 1 article reviews
    recombinant mouse il 17a - by Bioz Stars, 2026-05
    93/100 stars
      Buy from Supplier

    95
    R&D Systems il17a
    Il17a, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/il17a/product/R&D Systems
    Average 95 stars, based on 1 article reviews
    il17a - by Bioz Stars, 2026-05
    95/100 stars
      Buy from Supplier

    94
    R&D Systems mouse il 17a
    a–c, Proposed model illustrating how effector cytokines produced by infiltrating Th1 and Th17 lymphocytes following repeated GAS infections may differentially shape transcriptional responses in brain endothelial cells (BECs) and microglia. a, IFNγ is predicted to contribute to the induction of interferon-response programs and antigen-presentation pathways in both microglia and BECs. <t>b,c,</t> <t>IL-17A</t> and GM-CSF appear to exert partially overlapping effects on microglial activation, including regulation of proliferative responses and induction of disease-associated microglial (DAM) genes, cytokines, and chemokines, while also displaying cytokine-specific contributions. Notably, IL-17A signaling may more strongly influence endothelial transcriptional alterations following GAS infections. In addition, antigen-presentation signatures remain elevated in conditions of Th17 deficiency or systemic IL-17A neutralization, suggesting that IL-17A may normally modulate these pathways in both microglia and BECs. Together, these models highlight shared and distinct roles for Th17-associated cytokines in shaping neuroimmune and vascular responses after recurrent GAS exposure.
    Mouse Il 17a, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse il 17a/product/R&D Systems
    Average 94 stars, based on 1 article reviews
    mouse il 17a - by Bioz Stars, 2026-05
    94/100 stars
      Buy from Supplier

    95
    R&D Systems mouse recombinant il 17a
    a–c, Proposed model illustrating how effector cytokines produced by infiltrating Th1 and Th17 lymphocytes following repeated GAS infections may differentially shape transcriptional responses in brain endothelial cells (BECs) and microglia. a, IFNγ is predicted to contribute to the induction of interferon-response programs and antigen-presentation pathways in both microglia and BECs. <t>b,c,</t> <t>IL-17A</t> and GM-CSF appear to exert partially overlapping effects on microglial activation, including regulation of proliferative responses and induction of disease-associated microglial (DAM) genes, cytokines, and chemokines, while also displaying cytokine-specific contributions. Notably, IL-17A signaling may more strongly influence endothelial transcriptional alterations following GAS infections. In addition, antigen-presentation signatures remain elevated in conditions of Th17 deficiency or systemic IL-17A neutralization, suggesting that IL-17A may normally modulate these pathways in both microglia and BECs. Together, these models highlight shared and distinct roles for Th17-associated cytokines in shaping neuroimmune and vascular responses after recurrent GAS exposure.
    Mouse Recombinant Il 17a, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse recombinant il 17a/product/R&D Systems
    Average 95 stars, based on 1 article reviews
    mouse recombinant il 17a - by Bioz Stars, 2026-05
    95/100 stars
      Buy from Supplier

    94
    R&D Systems protein
    a–c, Proposed model illustrating how effector cytokines produced by infiltrating Th1 and Th17 lymphocytes following repeated GAS infections may differentially shape transcriptional responses in brain endothelial cells (BECs) and microglia. a, IFNγ is predicted to contribute to the induction of interferon-response programs and antigen-presentation pathways in both microglia and BECs. <t>b,c,</t> <t>IL-17A</t> and GM-CSF appear to exert partially overlapping effects on microglial activation, including regulation of proliferative responses and induction of disease-associated microglial (DAM) genes, cytokines, and chemokines, while also displaying cytokine-specific contributions. Notably, IL-17A signaling may more strongly influence endothelial transcriptional alterations following GAS infections. In addition, antigen-presentation signatures remain elevated in conditions of Th17 deficiency or systemic IL-17A neutralization, suggesting that IL-17A may normally modulate these pathways in both microglia and BECs. Together, these models highlight shared and distinct roles for Th17-associated cytokines in shaping neuroimmune and vascular responses after recurrent GAS exposure.
    Protein, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/protein/product/R&D Systems
    Average 94 stars, based on 1 article reviews
    protein - by Bioz Stars, 2026-05
    94/100 stars
      Buy from Supplier

    94
    R&D Systems recombinant il 17a
    a–c, Proposed model illustrating how effector cytokines produced by infiltrating Th1 and Th17 lymphocytes following repeated GAS infections may differentially shape transcriptional responses in brain endothelial cells (BECs) and microglia. a, IFNγ is predicted to contribute to the induction of interferon-response programs and antigen-presentation pathways in both microglia and BECs. <t>b,c,</t> <t>IL-17A</t> and GM-CSF appear to exert partially overlapping effects on microglial activation, including regulation of proliferative responses and induction of disease-associated microglial (DAM) genes, cytokines, and chemokines, while also displaying cytokine-specific contributions. Notably, IL-17A signaling may more strongly influence endothelial transcriptional alterations following GAS infections. In addition, antigen-presentation signatures remain elevated in conditions of Th17 deficiency or systemic IL-17A neutralization, suggesting that IL-17A may normally modulate these pathways in both microglia and BECs. Together, these models highlight shared and distinct roles for Th17-associated cytokines in shaping neuroimmune and vascular responses after recurrent GAS exposure.
    Recombinant Il 17a, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/recombinant il 17a/product/R&D Systems
    Average 94 stars, based on 1 article reviews
    recombinant il 17a - by Bioz Stars, 2026-05
    94/100 stars
      Buy from Supplier

    Image Search Results


    a–c, Proposed model illustrating how effector cytokines produced by infiltrating Th1 and Th17 lymphocytes following repeated GAS infections may differentially shape transcriptional responses in brain endothelial cells (BECs) and microglia. a, IFNγ is predicted to contribute to the induction of interferon-response programs and antigen-presentation pathways in both microglia and BECs. b,c, IL-17A and GM-CSF appear to exert partially overlapping effects on microglial activation, including regulation of proliferative responses and induction of disease-associated microglial (DAM) genes, cytokines, and chemokines, while also displaying cytokine-specific contributions. Notably, IL-17A signaling may more strongly influence endothelial transcriptional alterations following GAS infections. In addition, antigen-presentation signatures remain elevated in conditions of Th17 deficiency or systemic IL-17A neutralization, suggesting that IL-17A may normally modulate these pathways in both microglia and BECs. Together, these models highlight shared and distinct roles for Th17-associated cytokines in shaping neuroimmune and vascular responses after recurrent GAS exposure.

    Journal: bioRxiv

    Article Title: Th17 effector cytokines induce shared and distinct microglial and endothelial cell responses in post-streptococcal encephalitis

    doi: 10.64898/2026.02.04.703836

    Figure Lengend Snippet: a–c, Proposed model illustrating how effector cytokines produced by infiltrating Th1 and Th17 lymphocytes following repeated GAS infections may differentially shape transcriptional responses in brain endothelial cells (BECs) and microglia. a, IFNγ is predicted to contribute to the induction of interferon-response programs and antigen-presentation pathways in both microglia and BECs. b,c, IL-17A and GM-CSF appear to exert partially overlapping effects on microglial activation, including regulation of proliferative responses and induction of disease-associated microglial (DAM) genes, cytokines, and chemokines, while also displaying cytokine-specific contributions. Notably, IL-17A signaling may more strongly influence endothelial transcriptional alterations following GAS infections. In addition, antigen-presentation signatures remain elevated in conditions of Th17 deficiency or systemic IL-17A neutralization, suggesting that IL-17A may normally modulate these pathways in both microglia and BECs. Together, these models highlight shared and distinct roles for Th17-associated cytokines in shaping neuroimmune and vascular responses after recurrent GAS exposure.

    Article Snippet: Media containing either mouse IFNγ (R&D Systems, 485-MI-100), mouse IL-17A (R&D Systems, 7956-ML-025), mouse GM-CSF (R&D Systems, 415-ML-010) or vehicle (PBS with Ca 2+ and Mg 2+ ) was applied to corresponding wells.

    Techniques: Produced, Immunopeptidomics, Activation Assay, Neutralization

    a, Timeline of recurrent intranasal GAS infections and administration of an α–IL-17A–neutralizing monoclonal antibody (mAb) or isotype control. b, Heat maps of differentially expressed genes (DEGs) related to BBB function, LPS response, interferon signaling, and antigen presentation in olfactory bulb (OB) brain endothelial cells (BECs) from GAS-infected mice treated with isotype control or α–IL-17A mAb. Values are shown as log(z-score); significantly altered genes are indicated in black (adjusted p < 0.05). c, Gene ontology (GO) pathway enrichment analysis of transcripts upregulated and downregulated in α–IL-17A mAb–treated versus isotype-treated BECs following GAS infections. d, Representative immunofluorescence (IF) images of endogenous IgG leakage (green) in the granular layer of the OB. Blood vessels are labeled with Glut1 (cyan). e, f, Quantification of IgG extravasation (relative fluorescence intensity) in the glomerular ( e ) and granular ( f ) OB layers from PBS- or GAS-infected mice treated with α–IL-17A mAb or isotype control. Comparisons were performed using two-way ANOVA with Šídák’s multiple comparisons test ( p < 0.05; ** p < 0.001; n = 3–7 mice per group). g–i, Representative IF images for IFITM3 (pink), Iba1 (yellow), and CD31 (blue) in the OB of GAS-infected mice treated with isotype or α–IL-17A mAb ( g,h ), and quantification of Ifitm3-positive area within CD31⁺ vasculature ( i ). j,k, Representative fluorescence in situ hybridization (FISH) images of Itm2a mRNA (pink) combined with Glut1 (blue) in the glomerular layer ( j ) and quantification of vascular Itm2a signal ( k ). l, Representative IF images of the tight junction proteins Claudin-5 (green) and ZO-1 (red) in the OB vasculature of GAS-infected mice treated with isotype or α–IL-17A mAb. m, Serum cytokine concentrations measured by multiplex immunoassay in PBS- or GAS-infected mice treated with isotype or α–IL-17A mAb. Data are mean ± SEM. Comparisons were performed using one-way ANOVA with Tukey’s multiple comparisons test (ns, p > 0.05; p < 0.05; * p < 0.01; ** p < 0.001; *** p < 0.0001; n = 3 - 6 mice per group). n, Survival curves of GAS-infected mice treated with isotype control or α–IL-17A mAb (n = 13–48 mice per group). Statistical significance was assessed using the Mantel–Cox log-rank test.

    Journal: bioRxiv

    Article Title: Th17 effector cytokines induce shared and distinct microglial and endothelial cell responses in post-streptococcal encephalitis

    doi: 10.64898/2026.02.04.703836

    Figure Lengend Snippet: a, Timeline of recurrent intranasal GAS infections and administration of an α–IL-17A–neutralizing monoclonal antibody (mAb) or isotype control. b, Heat maps of differentially expressed genes (DEGs) related to BBB function, LPS response, interferon signaling, and antigen presentation in olfactory bulb (OB) brain endothelial cells (BECs) from GAS-infected mice treated with isotype control or α–IL-17A mAb. Values are shown as log(z-score); significantly altered genes are indicated in black (adjusted p < 0.05). c, Gene ontology (GO) pathway enrichment analysis of transcripts upregulated and downregulated in α–IL-17A mAb–treated versus isotype-treated BECs following GAS infections. d, Representative immunofluorescence (IF) images of endogenous IgG leakage (green) in the granular layer of the OB. Blood vessels are labeled with Glut1 (cyan). e, f, Quantification of IgG extravasation (relative fluorescence intensity) in the glomerular ( e ) and granular ( f ) OB layers from PBS- or GAS-infected mice treated with α–IL-17A mAb or isotype control. Comparisons were performed using two-way ANOVA with Šídák’s multiple comparisons test ( p < 0.05; ** p < 0.001; n = 3–7 mice per group). g–i, Representative IF images for IFITM3 (pink), Iba1 (yellow), and CD31 (blue) in the OB of GAS-infected mice treated with isotype or α–IL-17A mAb ( g,h ), and quantification of Ifitm3-positive area within CD31⁺ vasculature ( i ). j,k, Representative fluorescence in situ hybridization (FISH) images of Itm2a mRNA (pink) combined with Glut1 (blue) in the glomerular layer ( j ) and quantification of vascular Itm2a signal ( k ). l, Representative IF images of the tight junction proteins Claudin-5 (green) and ZO-1 (red) in the OB vasculature of GAS-infected mice treated with isotype or α–IL-17A mAb. m, Serum cytokine concentrations measured by multiplex immunoassay in PBS- or GAS-infected mice treated with isotype or α–IL-17A mAb. Data are mean ± SEM. Comparisons were performed using one-way ANOVA with Tukey’s multiple comparisons test (ns, p > 0.05; p < 0.05; * p < 0.01; ** p < 0.001; *** p < 0.0001; n = 3 - 6 mice per group). n, Survival curves of GAS-infected mice treated with isotype control or α–IL-17A mAb (n = 13–48 mice per group). Statistical significance was assessed using the Mantel–Cox log-rank test.

    Article Snippet: Media containing either mouse IFNγ (R&D Systems, 485-MI-100), mouse IL-17A (R&D Systems, 7956-ML-025), mouse GM-CSF (R&D Systems, 415-ML-010) or vehicle (PBS with Ca 2+ and Mg 2+ ) was applied to corresponding wells.

    Techniques: Control, Immunopeptidomics, Olfactory, Infection, Immunofluorescence, Labeling, Fluorescence, In Situ Hybridization, Multiplex Assay